Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat

  • Diagnostics guidance
  • DG10
  • Published: 

This guidance has been updated and replaced by NICE diagnostics guidance 34.